AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 480
- Registration Number
- NCT00163423
- Locations
- 🇿🇦
Altana Pharma/Nycomed, Wynberg, South Africa
Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 20
- Registration Number
- NCT00163345
- Locations
- 🇳🇱
Altana Pharma/Nycomed, RB Groningen, Netherlands
Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 636
- Registration Number
- NCT00163514
- Locations
- 🇨🇦
Altana Pharma/Nycomed, Winnipeg, Canada
Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 600
- Registration Number
- NCT00163501
- Locations
- 🇺🇸
Altana Pharma/Nycomed, Milwaukee, Wisconsin, United States
Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 450
- Registration Number
- NCT00163436
- Locations
- 🇮🇹
Altana Pharma/Nycomed, Verona, Italy
Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 500
- Registration Number
- NCT00163319
- Locations
- 🇬🇧
Altana Pharma/Nycomed, Watford, United Kingdom
Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101)
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 240
- Registration Number
- NCT00163293
- Locations
- 🇿🇦
Altana Pharma/Nycomed, Kapstadt, South Africa
Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00163332
- Locations
- 🇧🇪
Altana Pharma/Nycomed, Liége, Belgium
Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 500
- Registration Number
- NCT00163410
- Locations
- 🇮🇳
Altana Pharma/Nycomed, Shastri Nagar, Jaipur, India
Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT00163449
- Locations
- 🇨🇭
Altana Pharma/Nycomed, Zürich, Switzerland
© Copyright 2024. All Rights Reserved by MedPath